We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
A recent decision of the European Court of Justice suggests that the Court is beginning to adopt a strict interpretation as to what could constitute the "promotion" of medicinal products in the European Union
